Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

APOE genotype and cognitive functioning in a large age-stratified population sample.

Jorm AF, Mather KA, Butterworth P, Anstey KJ, Christensen H, Easteal S.

Neuropsychology. 2007 Jan;21(1):1-8.

PMID:
17201525
2.

Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?

Small BJ, Graves AB, McEvoy CL, Crawford FC, Mullan M, Mortimer JA.

Neurology. 2000 Jun 13;54(11):2082-8.

PMID:
10851367
3.

Apolipoprotein E and cognitive performance: a meta-analysis.

Small BJ, Rosnick CB, Fratiglioni L, Bäckman L.

Psychol Aging. 2004 Dec;19(4):592-600.

PMID:
15584785
4.

Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease.

Tröster AI, Fields JA, Paolo AM, Koller WC.

J Neurol Sci. 2006 Oct 25;248(1-2):62-7.

PMID:
16769085
5.

Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults.

Sawyer K, Sachs-Ericsson N, Preacher KJ, Blazer DG.

Gerontology. 2009;55(1):32-40. doi: 10.1159/000137666. Epub 2008 Jun 5.

PMID:
18525196
6.

Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction.

Feng L, Li J, Yap KB, Kua EH, Ng TP.

Am J Clin Nutr. 2009 Apr;89(4):1263-8. doi: 10.3945/ajcn.2008.26969. Epub 2009 Feb 25.

7.

Cognitive impairment in Alzheimer's disease is modified by APOE genotype.

van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.

Dement Geriatr Cogn Disord. 2007;24(2):98-103. Epub 2007 Jun 26.

PMID:
17596691
8.

Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.

Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.

J Clin Psychiatry. 2009 Oct;70(10):1379-84. doi: 10.4088/JCP.08m04593. Epub 2009 Jun 30.

PMID:
19573495
9.

Epistasis between APOE and nicotinic receptor gene CHRNA4 in age related cognitive function and decline.

Reinvang I, Lundervold AJ, Wehling E, Rootwelt H, Espeseth T.

J Int Neuropsychol Soc. 2010 May;16(3):424-32. doi: 10.1017/S1355617710000263. Epub 2010 Mar 24.

PMID:
20331911
10.

Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.

Bracco L, Piccini C, Baccini M, Bessi V, Biancucci F, Nacmias B, Bagnoli S, Sorbi S.

Dement Geriatr Cogn Disord. 2007;24(6):483-91. Epub 2007 Nov 15.

PMID:
18025782
11.

Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.

O'Hara R, Sommer B, Way N, Kraemer HC, Taylor J, Murphy G.

J Psychiatr Res. 2008 Feb;42(3):199-204. Epub 2007 Jan 23.

PMID:
17250852
12.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
13.

Working memory deficits in healthy APOE epsilon 4 carriers.

Reinvang I, Winjevoll IL, Rootwelt H, Espeseth T.

Neuropsychologia. 2010 Jan;48(2):566-73. doi: 10.1016/j.neuropsychologia.2009.10.018. Epub 2009 Oct 29.

PMID:
19879282
14.

Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.

Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, Ordonez-Sanchez ML, Gutierrez-Robledo LM.

J Am Geriatr Soc. 2008 Apr;56(4):677-82. doi: 10.1111/j.1532-5415.2007.01606.x. Epub 2008 Jan 16.

PMID:
18205760
15.

The apolipoprotein E gene and its age-specific effects on cognitive function.

Liu F, Pardo LM, Schuur M, Sanchez-Juan P, Isaacs A, Sleegers K, de Koning I, Zorkoltseva IV, Axenovich TI, Witteman JC, Janssens AC, van Swieten JC, Aulchenko YS, Oostra BA, van Duijn CM.

Neurobiol Aging. 2010 Oct;31(10):1831-3. doi: 10.1016/j.neurobiolaging.2008.09.015. Epub 2008 Nov 11.

PMID:
19004527
16.

A comparison of cognitive functioning in older adults with and without traumatic brain injury.

Ashman TA, Cantor JB, Gordon WA, Sacks A, Spielman L, Egan M, Hibbard MR.

J Head Trauma Rehabil. 2008 May-Jun;23(3):139-48. doi: 10.1097/01.HTR.0000319930.69343.64.

PMID:
18520426
17.

APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.

van Vliet P, Oleksik AM, Mooijaart SP, de Craen AJ, Westendorp RG.

Neurology. 2009 Mar 3;72(9):821-8. doi: 10.1212/01.wnl.0000343852.10018.24.

PMID:
19255409
18.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
19.

APOE-epsilon4 polymorphism and cognitive deficit among the elderly population of Fernando de Noronha.

Garcia AN, Silva HA, Silva RC, Leal EM, Rodrigues L, Silva VC, Dellalibera E, Freitas EM, Ataíde L Jr, Muniz MT.

Arq Neuropsiquiatr. 2008 Jun;66(2B):298-302.

20.

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.

Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.

Pharmacogenet Genomics. 2008 Apr;18(4):289-98. doi: 10.1097/FPC.0b013e3282f63f29.

PMID:
18334913

Supplemental Content

Support Center